Professor Sir Nicholas J White
Artemisinin therapy for malaria
Malaria kills more than half a million people every year. Following a number of groundbreaking clinical trials, Professor Sir Nick White and his Thailand team successfully demonstrated the effectiveness of artemisinin drug therapy for malaria in adults, children and infants. He also pioneered artemisinin combination therapy, the first-line treatment for malaria worldwide.
Professor of Tropical Medicine
- Professor at Mahidol University in Thailand
Professor White’s diverse interests include the epidemiology, pathophysiology and management of uncomplicated and severe malaria, meliodosis, enteric fever, tetanus, dengue haemorrhagic fever, Japanese encephalitis and tuberculosis. His particular interests at present include the pathophysiology and treatment of severe malaria, the prevention of antimalarial drug resistance using artemisinin-based combinations. and the biology of relapse in vivax malaria.
Chotsiri P. et al, (2022), Clin Pharmacol Ther
White NJ., (2022), Blood, 139, 2268 - 2269
Chandna A. et al, (2022), Wellcome Open Research, 6, 64 - 64
White NJ. et al, (2022), Lancet (London, England), 399, 799 - 800
White NJ. et al, (2022), British Journal of Clinical Pharmacology